Sijy O’Dell

2008–2024 年に発表

81
論文数
23,169
被引用数
62
h 指数
79
i10 指数

被引用数

Sijy O’Dell の年別被引用数1993 年: 被引用 4 件2000 年: 被引用 1 件2003 年: 被引用 4 件2005 年: 被引用 1 件2009 年: 被引用 18 件2010 年: 被引用 35 件2011 年: 被引用 87 件2012 年: 被引用 185 件2013 年: 被引用 225 件2014 年: 被引用 180 件2015 年: 被引用 249 件2016 年: 被引用 351 件2017 年: 被引用 312 件2018 年: 被引用 308 件2019 年: 被引用 702 件2020 年: 被引用 1,058 件2021 年: 被引用 2,544 件2022 年: 被引用 1,709 件2023 年: 被引用 738 件2024 年: 被引用 808 件2025 年: 被引用 395 件2026 年: 被引用 3 件1994〜1999 年は被引用が無いため表示していません2001〜2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません2006〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,279 件、この内訳の 35.3%中国: 引用元論文 702 件、この内訳の 7.5%イギリス: 引用元論文 569 件、この内訳の 6.1%ドイツ: 引用元論文 378 件、この内訳の 4.1%カナダ: 引用元論文 302 件、この内訳の 3.2%イタリア: 引用元論文 268 件、この内訳の 2.9%オランダ: 引用元論文 266 件、この内訳の 2.9%フランス: 引用元論文 260 件、この内訳の 2.8%オーストラリア: 引用元論文 212 件、この内訳の 2.3%インド: 引用元論文 210 件、この内訳の 2.3%スイス: 引用元論文 188 件、この内訳の 2%南アフリカ: 引用元論文 184 件、この内訳の 2%
0%35.3%その他 26.6%

分野

  • Medicine59.2%
  • Immunology and Microbiology23.9%
  • Biochemistry, Genetics and Molecular Biology12.6%
  • Social Sciences1%
  • Mathematics0.6%
  • Agricultural and Biological Sciences0.5%
  • その他2.2%

トピック

  • SARS-CoV-2 and COVID-19 Research17.3%
  • COVID-19 Clinical Research Studies7.5%
  • HIV Research and Treatment7.1%
  • vaccines and immunoinformatics approaches4.5%
  • Monoclonal and Polyclonal Antibodies Research4.4%
  • Immunotherapy and Immune Responses3.8%
  • その他55.4%

共著者

全論文

検索で開く
  1. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julie E. Ledgerwood, Barney S. Graham, John H. Beigel - New England Journal of Medicine 2020 被引用: 3,487

  2. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wendy Buchanan, Catherine J. Luke, Varun K. Phadke, Christina A. Rostad, Julie E. Ledgerwood, Barney S. Graham, John H. Beigel - New England Journal of Medicine 2020 被引用: 1,630

  3. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurent Pessaint, Alex Van Ry, Shanai Browne, Jack Greenhouse, Tammy Taylor, Amanda Strasbaugh, Tracey-Ann Campbell, Anthony Cook, Alan Dodson, Katelyn Steingrebe, Wei Shi, Yi Zhang, Olubukola M. Abiona, Lingshu Wang, Amarendra Pegu, Eun Sung Yang, Kwanyee Leung, Tongqing Zhou, I‐Ting Teng, Alicia T. Widge, Ingelise J. Gordon, Laura Novik, Rebecca A. Gillespie, Rebecca J. Loomis, Juan I. Moliva, Guillaume B. E. Stewart-Jones, Sunny Himansu, Wing‐Pui Kong, Martha Nason, Kaitlyn M. Morabito, Tracy J. Ruckwardt, Julie E. Ledgerwood, Martin R. Gaudinski, Peter D. Kwong, John R. Mascola, Andrea Carfı́, Mark G. Lewis, Ralph S. Baric, Adrian B. McDermott, Ian N. Moore, Nancy J. Sullivan, Mario Roederer, Robert A. Seder, Barney S. Graham - New England Journal of Medicine 2020 被引用: 1,174

  4. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Science 2010 被引用: 1,802

  5. Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 182

  6. Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Seaman, Lawrence Shapiro, John R. Mascola, Peter D. Kwong, Mark Connors - Immunity 2016 被引用: 395

  7. Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mehul S. Suthar, Adrian B. McDermott, Nicole A. Doria‐Rose, Jae Arega, John H. Beigel, Wendy Buchanan, Mohammed Elsafy, Binh Hoang, Rebecca Lampley, Aparna Kolhekar, Hyung Il Koo, Catherine J. Luke, Mamodikoe Makhene, Seema Nayak, Rhonda Pikaart-Tautges, Paul C. Roberts, Janie Russell, Elisa Sindall, Jim Albert, Pratap Kunwar, Mat Makowski, Evan J. Anderson, Amer Bechnak, Mary Bower, Andrés Camacho-González, Matthew H. Collins, Ana Drobeniuc, Venkata Viswanadh Edara, Srilatha Edupuganti, Katharine Floyd, Theda Gibson, Cassie M. Grimsley Ackerley, Brandi Johnson, Satoshi Kamidani, Carol Kao, Colleen F. Kelley, Lilin Lai, Hollie Macenczak, Michele Paine McCullough, Etza Peters, Varun K. Phadke, Paulina A. Rebolledo, Christina A. Rostad, Nadine Rouphael, Erin M. Scherer, Amy C Sherman, Kathy Stephens, Mehul S. Suthar, Mehgan Teherani, Jessica Traenkner, Juton R. Winston, İnci Yıldırım, Lee Barr, Joyce Benoit, Barbara Carste, Joe Choe, Maya Dunstan, Roxanne Erolin, Jana ffitch, Colin Fields, Lisa A. Jackson, Erika Kiniry, Susan Lasicka, Stella E. Lee, M. Nguyen, Stephanie Pimienta, Janice Suyehira, Michael M. Witte, Hamilton Bennett, Nedim Emil Altaras ほか 58 名 - Science 2021 被引用: 602

  8. Defining the risk of SARS-CoV-2 variants on immune protection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ali H. Ellebedy, Thomas Fabrizio, Guido Ferrari, Will Fischer, William C. Florence, Ron A. M. Fouchier, John Franks, Adolfo Garcı́a-Sastre, Adam Godzik, Ana S. Gonzalez‐Reiche, Aubree Gordon, Bart L. Haagmans, Peter Halfmann, David D. Ho, Michael R. Holbrook, Yaoxing Huang, Sarah L. James, Lukasz Jaroszewski, Trushar Jeevan, Robert M. Johnson, Terry C. Jones, Astha Joshi, Yoshihiro Kawaoka, Lisa Kercher, Marion Koopmans, Bette Korber, Eilay Koren, Richard A. Koup, Eric B. LeGresley, Jacob E. Lemieux, Mariel J. Liebeskind, Zhuoming Liu, Brandi Livingston, James Logue, Yang Luo, Adrian B. McDermott, Margaret Juliana McElrath, Victoria Meliopoulos, Vineet D. Menachery, David C. Montefiori, Barbara Mühlemann, Vincent J. Munster, Jenny Munt, Manoj S. Nair, Antonia Netzl, Anna Maria Niewiadomska, Sijy O’Dell, Andrew Pekosz, Stanley Perlman, Marjorie Cornejo Pontelli, Barry Rockx, Morgane Rolland, Paul W. Rothlauf, Sinai Sacharen, Richard H. Scheuermann, Stephen D. Schmidt, Michael Schotsaert, Stacey Schultz‐Cherry, Robert A. Seder, Mayya Sedova, Alessandro Sette, Reed S. Shabman, Xiaoying Shen, Pei‐Yong Shi, Maulik Shukla, Viviana Simon, Spencer Stumpf, Nancy J. Sullivan, Larissa B. Thackray, James Theiler ほか 30 名 - Nature 2022 被引用: 185

  9. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yongping Yang, Zhenhai Zhang, NISC Comparative Sequencing, James C. Mullikin, James Μ. Binley, Rogier W. Sanders, Ian A. Wilson, John P. Moore, Andrew C. Ward, George Georgiou, Carolyn Williamson, Salim S. Abdool Karim, Lynn Morris, Peter D. Kwong, Lawrence Shapiro, John R. Mascola - Nature 2014 被引用: 756

  10. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Stuckey, Paul V. Thomas, Tishina Tittley, Constance Williams, Baoshan Zhang, Hong Zhao, Zhou Zhou, Bruce R. Donald, Lawrence K. Lee, Susan Zolla‐Pazner, Ulrich Baxa, Arne Schön, Ernesto Freire, Lawrence Shapiro, Kelly K. Lee, James Arthos, James B. Munro, Scott C. Blanchard, Walther Mothes, James Μ. Binley, Adrian B. McDermott, John R. Mascola, Peter D. Kwong - Nature Structural & Molecular Biology 2015 被引用: 368

  11. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Valentin, Anthony Cook, Alan Dodson, Katelyn Steingrebe, Saule Nurmukhambetova, Sucheta Godbole, Amy R. Henry, Farida Laboune, Jesmine Roberts-Torres, Cynthia G. Lorang, Shivani Amin, Jessica F. Trost, Mursal Naisan, Manjula Basappa, Jacquelyn Willis, Lingshu Wang, Wei Shi, Nicole A. Doria‐Rose, Yi Zhang, Eun Sung Yang, Kwanyee Leung, Sijy O’Dell, Stephen D. Schmidt, Adam S. Olia, Cuiping Liu, Darcy R. Harris, Gwo‐Yu Chuang, Guillaume B. E. Stewart-Jones, Isabella Renzi, Yen‐Ting Lai, Agata Malinowski, Kaichun Wu, John R. Mascola, Andrea Carfı́, Peter D. Kwong, Darin K. Edwards, Mark G. Lewis, Hanné Andersen, Kizzmekia S. Corbett, Martha Nason, Adrian B. McDermott, Mehul S. Suthar, Ian N. Moore, Mario Roederer, Nancy J. Sullivan, Daniel C. Douek, Robert A. Seder - Cell 2022 被引用: 228

  12. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Koup, Daniel C. Douek, Zonghui Hu, Edmund V. Capparelli, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, VRC 601 Study Team - Science Translational Medicine 2015 被引用: 479

  13. SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alicia Widge, Nancy J. Sullivan, Paul C. Roberts, John H. Beigel, Bette Korber, Lindsey R. Baden, Hana El Sahly, Spyros Chalkias, Honghong Zhou, Jing Feng, Bethany Girard, Rituparna Das, Anne Aunins, Darin K. Edwards, Mehul S. Suthar, John R. Mascola, David C. Montefiori - New England Journal of Medicine 2022 被引用: 391

  14. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 754

  15. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yen‐Ting Lai, Thomas Lemmin, Krisha McKee, Tiffany Y. Ohr, Li Ou, Dongjun Peng, Ariana P. Rowshan, Zizhang Sheng, John-Paul Todd, Yaroslav Tsybovsky, Elise G. Viox, Yiran Wang, Hui Wei, Yongping Yang, Amy F. Zhou, Rui Chen, Lu Yang, Diana G. Scorpio, Adrian B. McDermott, Lawrence Shapiro, Bridget Carragher, Clinton S. Potter, John R. Mascola, Peter D. Kwong - Nature Medicine 2018 被引用: 310

  16. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xuejun Chen, Florence Kaltovich, Kevin O. Saunders, Judy Stein, Nicole A. Doria‐Rose, Richard Schwartz, Alejandro B. Balazs, David Baltimore, Gary J. Nabel, Richard A. Koup, Barney S. Graham, Julie E. Ledgerwood, John R. Mascola, the VRC 603 Study Team, Charla Andrews, Anita Arthur, Seemal F. Awan, Allison Beck, Eugeania Burch, Maria Claudia Burgos Florez, Nina M. Berkowitz, Eli Boritz, Kevin Carlton, Cora Trelles Cartagena, Christina Carter, Grace Chen, Pamela Costner, Jennifer Cunningham, Daniel C. Douek, Aba M. Eshun, Catina Evans, Renunda Hicks, Katherine V. Houser, Justine Jones, Brenda Larkin, Lam Le, Floreliz Mendoza, Stephen A. Migueles, John Misasi, Thuy A. Nguyen, Abidemi Ola, Karen Parker, Iris Pittman, La’ Shawn Requilman, Ro Shauna Rothwell, Gretchen L. Schieber, Jamie Saunders, Sandra Sitar, Colin Tran, Olga Trofymenko, Olga Vasilenko, Sana Waheed, Lingshu Wang, Xiaolin Wang, William Whalen, Pernell Williams, Richard L. C. Wu, Kathy Zephir - Nature Medicine 2022 被引用: 94

  17. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hung‐Pin Peng, An‐Suei Yang, James C. Mullikin, Matthew D. Gray, Leonidas Stamatatos, Dennis R. Burton, Wayne C. Koff, Myron S. Cohen, Barton F. Haynes, Joseph P. Casazza, Mark Connors, Davide Corti, Antonio Lanzavecchia, Quentin J. Sattentau, Robin A. Weiss, Anthony P. West, Pamela J. Björkman, Johannes F. Scheid, Michel C. Nussenzweig, Lawrence Shapiro, John R. Mascola, Peter D. Kwong - Cell 2015 被引用: 340

  18. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynn Morris, John R. Mascola - Journal of Virology 2015 被引用: 261

  19. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John H. Beigel - New England Journal of Medicine 2020 被引用: 829

  20. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel E. Sam, Barton F. Haynes, Dennis R. Burton, Wayne C. Koff, Laura M. Walker, Sanjay Phogat, Richard T. Wyatt, Jared Orwenyo, Lai‐Xi Wang, James Arthos, Carole A. Bewley, John R. Mascola, Gary J. Nabel, William R. Schief, Andrew B. Ward, Ian A. Wilson, Peter D. Kwong - Nature 2011 被引用: 853

  21. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Connors, Andrew B. Ward, Peter D. Kwong, John R. Mascola - Science 2016 被引用: 377

  22. Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James C. Mullikin, Lawrence Shapiro, Richard A. Koup, Barney S. Graham, Martha Nason, Mark Connors, Barton F. Haynes, Srinivas S. Rao, Mario Roederer, Peter D. Kwong, John R. Mascola, Gary J. Nabel - Journal of Virology 2014 被引用: 291

  23. Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 被引用: 105

  24. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Roederer, Mark Connors, Richard A. Koup, Peter D. Kwong, Zhiyong Yang, John R. Mascola, Gary J. Nabel - Science 2017 被引用: 271